根据最新提交给美国证券交易委员会（SEC）的文件显示，Mirum Pharmaceuticals, Inc.已正式登记由售股股东发起的普通股公开发行计划。此次发售规模最高可达896万股，所有股份均由现有股东提供，公司本身不会从此次发售中获得任何收益。
根据最新提交给美国证券交易委员会（SEC）的文件显示，Mirum Pharmaceuticals, Inc.已正式登记由售股股东发起的普通股公开发行计划。此次发售规模最高可达896万股，所有股份均由现有股东提供，公司本身不会从此次发售中获得任何收益。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.